C4 Therapeutics CCCC
NASDAQ CCCC
$3.78 +0.04 (+0.94%)
As of: Sep 4, 2026 · 12:50 PM EDT

C4 Therapeutics (CCCC) Preferred Dividend Payments (2020)

C4 Therapeutics (CCCC) posted quarterly Preferred Dividend Payments of $5.2 million for Q3 2020, up 79.23% quarter-over-quarter from $2.9 million in Q2 2020.

Analysis

C4 Therapeutics (CCCC) Preferred Dividend Payments (2020) Analysis & Trends

C4 Therapeutics' Preferred Dividend Payments history runs 1 years deep, the most recent figure standing at $5.2 million for Q3 2020.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn -
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn -
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn -
5 Revolution Medicines 44.05 Bn 44.05 Bn - -
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn -
8 Royalty Pharma 28.52 Bn 27.68 Bn - -
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn -
10 C4 Therapeutics 492.73 Mn 239.06 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 5.21 Mn
Jun 30, 2020 2.91 Mn
Mar 31, 2020 2.11 Mn